- Public Comps
- PsyRx CNS Bio-Tech
PsyRx CNS Bio-Tech Valuation Multiples
Discover revenue and EBITDA valuation multiples for PsyRx CNS Bio-Tech and similar public comparables like Ubiquitech Software, Strainsforpains, Dogecoin Cash, CordovaCann and more.
PsyRx CNS Bio-Tech Overview
About PsyRx CNS Bio-Tech
Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.
Founded
2018
HQ

Employees
21
Website
Financials (FY)
Market Cap
$3M
Valuation Multiples
Start free trialPsyRx CNS Bio-Tech Stock Performance
PsyRx CNS Bio-Tech has current market cap of $3M.
Market Cap Evolution
PsyRx CNS Bio-Tech's stock price is $0.24.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $3M | -2.6% | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPsyRx CNS Bio-Tech Valuation Multiples
PsyRx CNS Bio-Tech Financial Valuation Multiples
As of September 17, 2026, PsyRx CNS Bio-Tech has market cap of $3M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PsyRx CNS Bio-Tech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


PsyRx CNS Bio-Tech Competitors
PsyRx CNS Bio-Tech competitors include Ubiquitech Software, Strainsforpains, Dogecoin Cash, CordovaCann, IM Cannabis, Neon Bloom, RAMM Pharma, Weed, Pharmadrug and Indoor Harvest.
Most PsyRx CNS Bio-Tech public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| - | - | - | - | |||
| 4.3x | - | (0.3x) | - | |||
| 0.7x | - | (12.6x) | - | |||
| 0.2x | - | (1.9x) | - | |||
| 0.5x | - | (0.6x) | - | |||
| 0.3x | - | (0.1x) | - | |||
| - | - | (3.6x) | - | |||
This data is available for Pro users. Sign up to see all PsyRx CNS Bio-Tech competitors and their valuation data. Start Free Trial | ||||||
PsyRx CNS Bio-Tech VC Funding History
Before going public, PsyRx CNS Bio-Tech raised $14M in total equity funding, across 4 rounds.
Last private valuation of PsyRx CNS Bio-Tech was $26M, after raising $4M in June 2020.
PsyRx CNS Bio-Tech Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PsyRx CNS Bio-Tech
| Who are competitors of PsyRx CNS Bio-Tech? | PsyRx CNS Bio-Tech main competitors include Ubiquitech Software, Strainsforpains, Dogecoin Cash, CordovaCann, IM Cannabis, Neon Bloom, RAMM Pharma, Weed, Pharmadrug, Indoor Harvest. |
See public comps similar to PsyRx CNS Bio-Tech
Lists including PsyRx CNS Bio-Tech
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




